Association between outdoor light at night and breast cancer risk among postmenopausal women

Outdoor light at night was linked to a higher risk of breast cancer in a recent study.

from Women's Health News -- ScienceDaily https://ift.tt/371SCwf

Association between outdoor light at night and breast cancer risk among postmenopausal women

Outdoor light at night was linked to a higher risk of breast cancer in a recent study.

from Breast Cancer News -- ScienceDaily https://ift.tt/371SCwf

Association between outdoor light at night and breast cancer risk among postmenopausal women

Outdoor light at night was linked to a higher risk of breast cancer in a recent study.

from Women's Health News -- ScienceDaily https://ift.tt/371SCwf

A satisfying romantic relationship may improve breast cancer survivors' health

Breast cancer survivors in romantic relationships who feel happy and satisfied with their partners may be at lower risk for a host of health problems, new research suggests.

from Breast Cancer News -- ScienceDaily https://ift.tt/2XvFf4o

Vitamin D determines severity in COVID-19 so government advice needs to change, experts urge

Researchers are urging the Irish government to immediately change recommendations on vitamin D supplements given recent changes by Welsh, English and Scottish governments.

from Women's Health News -- ScienceDaily https://ift.tt/2Z09gKL

Killing 'sleeper cells' may enhance breast cancer therapy

The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer, according to preclinical studies. The promising preclinical results for this 'triple therapy' have underpinned a phase 1 clinical trial in Melbourne, Australia, that is combining venetoclax with hormone therapy and CDK4/6 inhibitors in patients with ER+ breast cancer.

from Women's Health News -- ScienceDaily https://ift.tt/2YJeieg

Killing 'sleeper cells' may enhance breast cancer therapy

The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer, according to preclinical studies. The promising preclinical results for this 'triple therapy' have underpinned a phase 1 clinical trial in Melbourne, Australia, that is combining venetoclax with hormone therapy and CDK4/6 inhibitors in patients with ER+ breast cancer.

from Women's Health News -- ScienceDaily https://ift.tt/2YJeieg

Killing 'sleeper cells' may enhance breast cancer therapy

The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer, according to preclinical studies. The promising preclinical results for this 'triple therapy' have underpinned a phase 1 clinical trial in Melbourne, Australia, that is combining venetoclax with hormone therapy and CDK4/6 inhibitors in patients with ER+ breast cancer.

from Breast Cancer News -- ScienceDaily https://ift.tt/2YJeieg

Trial questions benefits of organic nitrates for bone health

A new study found that organic nitrates do not have clinically relevant effects on bone mineral density or bone turnover in postmenopausal women, and the medications caused significant side effects.

from Women's Health News -- ScienceDaily https://ift.tt/2zkYoft

Trial questions benefits of organic nitrates for bone health

A new study found that organic nitrates do not have clinically relevant effects on bone mineral density or bone turnover in postmenopausal women, and the medications caused significant side effects.

from Women's Health News -- ScienceDaily https://ift.tt/2zkYoft